Overview

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Status:
Completed
Trial end date:
2019-04-17
Target enrollment:
Participant gender:
Summary
Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of uncomplicated influenza.
Phase:
Phase 3
Details
Lead Sponsor:
Romark Laboratories L.C.
Treatments:
Nitazoxanide